Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jaka Dernovšek
Observed names:
Dernovšek, Jaka,
Dernovšek, Jaka,
J. Dernovšek
Institution:
University of Ljubljana
Observed institution:
University of Ljubljana
ORCID:
0000-0003-3370-8163
Observed ORCID:
0000-0003-3370-8163
OpenAlex ID:
A5088726604
Following the design path of isoform-selective Hsp90 inhibitors: Small differences, great opportunities
2023
·
Jaka Dernovšek
, Tihomir Tomašič
·
Pharmacology & Therapeutics
·
58
Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts
2023
·
C. Sturtzel
, S. Grissenberger
, et al.
·
npj Precision Oncology
·
55
Catalytic Stereoconvergent Synthesis of Homochiral β-CF 3 , β-SCF 3 , and β-OCF 3 Benzylic Alcohols
2022
·
Andrej Emanuel Cotman
, Pavel A. Dub
, et al.
·
ACS Organic & Inorganic Au
·
34
Benzimidazole–galactosides bind selectively to the Galectin-8 N-Terminal domain: Structure-based design and optimisation
2021
·
Mujtaba Hassan
, Sjors van Klaveren
, et al.
·
European Journal of Medicinal Chemistry
·
31
PDF
Structure-Activity Relationships of Benzothiazole-Based Hsp90 C-Terminal-Domain Inhibitors
2021
·
Jaka Dernovšek
, Živa Zajec
, et al.
·
Pharmaceutics
·
30
PDF
In Silico Discovery and Optimisation of a Novel Structural Class of Hsp90 C-Terminal Domain Inhibitors
2022
·
Živa Zajec
, Jaka Dernovšek
, et al.
·
Biomolecules
·
19
PDF
Optimisation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as novel Hsp90 C-terminal domain inhibitors against Ewing sarcoma
2022
·
Živa Zajec
, Jaka Dernovšek
, et al.
·
Bioorganic Chemistry
·
16
New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer
2024
·
Živa Zajec
, Jaka Dernovšek
, et al.
·
Journal of Medicinal Chemistry
·
15
Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1, -3 and -8 inhibitors
2022
·
Sjors van Klaveren
, Jaka Dernovšek
, et al.
·
RSC Advances
·
14
PDF
Exploration and optimisation of structure-activity relationships of new triazole-based C-terminal Hsp90 inhibitors towards in vivo anticancer potency
2024
·
Jaka Dernovšek
, Živa Zajec
, et al.
·
Biomedicine & Pharmacotherapy
·
12
PDF
New Diarylamine KV10.1 Inhibitors and Their Anticancer Potential
2022
·
Špela Gubič
, Žan Toplak
, et al.
·
Pharmaceutics
·
12
PDF
Discovery of new Hsp90–Cdc37 protein–protein interaction inhibitors: in silico screening and optimization of anticancer activity
2024
·
Jaka Dernovšek
, Nina Gradišek
, et al.
·
RSC Advances
·
8
PDF
Identification of a Novel Structural Class of HV1 Inhibitors by Structure-Based Virtual Screening
2024
·
Martina Piga
, Zoltan Varga
, et al.
·
Journal of Chemical Information and Modeling
·
8
PDF
New N -phenylpyrrolamide inhibitors of DNA gyrase with improved antibacterial activity
2024
·
Andrej Emanuel Cotman
, Federica Fulgheri
, et al.
·
RSC Advances
·
7
PDF
Improved N-phenylpyrrolamide inhibitors of DNA gyrase as antibacterial agents for high-priority bacterial strains
2024
·
Nace Zidar
, Alessia Onali
, et al.
·
European Journal of Medicinal Chemistry
·
7
Unveiling the antiglioblastoma potential of harmicens, harmine and ferrocene hybrids
2024
·
Goran Poje
, Davor Šakić
, et al.
·
Acta Pharmaceutica
·
6
PDF
Targeting voltage-gated proton channel HV1: Optimised 5-phenyl-2-aminoimidazoles with anticancer potential
2025
·
Martina Piga
, Geraldo Jorge Domingos
, et al.
·
European Journal of Medicinal Chemistry
·
5
Hiding in plain sight: Optimizing topoisomerase IIα inhibitors into Hsp90β selective binders
2024
·
Jaka Dernovšek
, Tjaša Goričan
, et al.
·
European Journal of Medicinal Chemistry
·
5
Computer-aided structure-based optimization of 4,5,6,7-tetrahydrobenzo[ d ]thiazole-2,6-diamine derivatives as DNA gyrase B inhibitors
2023
·
Lucas J. Gutierrez
, Marcela Vettorazzi
, et al.
·
New Journal of Chemistry
·
5
Development of narrow-spectrum topoisomerase-targeting antibacterials against mycobacteria
2024
·
Maša Sterle
, Eva Habjan
, et al.
·
European Journal of Medicinal Chemistry
·
4
PDF
First dual inhibitors of human topoisomerase IIα and Hsp90 C-terminal domain inhibit the growth of Ewing sarcoma in vitro and in vivo
2024
·
Jaka Dernovšek
, Dunja Urbančič
, et al.
·
Bioorganic Chemistry
·
3
Why choose between prediction power and mechanistic insight in QSRR modeling? A case study of artificial membrane chromatography and machine learning
2026
·
Wiktor Nisterenko
, Julia Nicman
, et al.
·
Analytica Chimica Acta
·
1
Hsp90 Inhibition on the Western Blot: N‐Terminal Versus C‐Terminal Inhibitors in Breast Cancer
2026
·
Jaka Dernovšek
, Jernej Cingl
, et al.
·
Medicinal Research Reviews
PDF
Correction to “Identification of a Novel Structural Class of HV1 Inhibitors by Structure-Based Virtual Screening”
2024
·
Martina Piga
, Zoltan Varga
, et al.
·
Journal of Chemical Information and Modeling
Design, synthesis and evaluation of new heat shock protein 90 inhibitors with anticancer activity
2024
·
Dernovšek, Jaka
·
Repository of the University of Ljubljana (University of Ljubljana)
Show more works
View as search
Works count:
35
Citation count:
355
H-index:
11
I10-index:
11
Year
Topic
Type